Dr Sónia Henriques researches peptides to treat cancer and infectious diseases. Her research group in Peptide Therapeutics and Membrane Biology focuses on characterizing cell membranes and in designing peptide therapeutics able to target unique cell membrane properties, cross cell membranes, and deliver drugs inside cancer/infectious cells. Dr Henriques graduated in Biochemistry (2003) and obtained a PhD degree in Biochemistry/Molecular Biophysics (2008) from the University of Lisbon in Portugal. She conducted postdoctoral research at the University of Queensland at the Institute for Molecular Bioscience (IMB) in Professor David Craik’s group, and at the University of Lisbon in Portugal in Professor Miguel Castanho’s group. She is the recipient of highly competitive fellowships (ARC Australian Postdoctoral Fellowship 2008; Marie Curie Fellowship 2009; ARC DECRA 2012; ARC Future Fellow 2015). She is a research group leader at the Translational Research Institute (TRI) and a senior lecturer in Biochemistry at Queensland University of Technology in Australia.